• No results found

Radiology of colorectal cancer with emphasis on imaging of liver metastases

N/A
N/A
Protected

Academic year: 2021

Share "Radiology of colorectal cancer with emphasis on imaging of liver metastases"

Copied!
3
0
0

Bezig met laden.... (Bekijk nu de volledige tekst)

Hele tekst

(1)

Radiology of colorectal cancer with emphasis on imaging of liver

metastases

Pijl, M.E.J.

Citation

Pijl, M. E. J. (2005, January 25). Radiology of colorectal cancer with emphasis on imaging of

liver metastases. Retrieved from https://hdl.handle.net/1887/3487

Version:

Not Applicable (or Unknown)

License:

Licence agreement concerning inclusion of doctoral thesis in the

Institutional Repository of the University of Leiden

Downloaded from:

https://hdl.handle.net/1887/3487

(2)
(3)

  &XUULFXOXP9LWDH

139

Referenties

GERELATEERDE DOCUMENTEN

Bartlett et al [12] reported a response rate of 74 percent, a median time to progression of 14.5 months and a median survival of 27 months after IHP with 1.5 mg/kg

The signal intensities (SI) of 48 liver metastases (originating from colorectal cancer) in 20 patients, the surrounding liver parenchyma and the background noise

Geconcludeerd mag worden dat de “ soft-copy” beoordeling van de series na toediening van intraveneus contrastmiddel voor de detectie van uitzaaiingen in en buiten de lever

Increased local cytostatic drug exposure by isolated hepatic perfusion: a phase I clinical and pharmacologic evaluation of treatment with high dose melphalan in patients

Vanaf j uli 1999 tot maart 2003 was zij werkzaam op de afdeling Radiologie van het Leids Universitair M edisch Centrum, waar zij het onderzoek verrichtte dat geleid heeft tot

Vervolgens was de auteur van dit proefschrift werkzaam als staflid Musculoskeletale Radiologie respectievelijk aan het Leids Universitair Medisch Centrum (Leiden,

Title: Risk quantification and modification in older patients with colorectal cancer Issue Date: 2020-11-12... S ou wer

Chapter 7 Radiofrequency ablation is beneficial in simultaneous treatment of synchronous liver metastases and primary colorectal cancer